Epigenetic reader chromodomain as a potential therapeutic target is a research paper published in RSC Chemical Biology (2025). On theSindex it has a DataRank of 0. It has been cited 5 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Welch Foundation
Grant: A-1715
Cancer Prevention and Research Institute of Texas
Grant: RP230345
Cancer Prevention and Research Institute of Texas
Grant: RP230449
National Institutes of Health
Grant: R01CA291968
National Institutes of Health
Grant: R35GM145351
National Institutes of Health
Grant: R01CA252707
National Institutes of Health
Grant: R01HL151334
National Institutes of Health
Grant: R01AG067664
NIA NIH HHS
Grant: R56 AG067664
National Institutes of Health
Grant: 5R35GM145351-03
Use of the Noncanonical Amino Acid Mutagenesis Technique in Combination with Other Approaches to Study Functions of Posttranslational Lysine Modifications in Proteins
National Institutes of Health
Grant: 1R01HL151334-01
The role of JADE in HBO complexes
National Institutes of Health
Grant: 1R01AG067664-01A1
Targeting acetylated histone H4 by MLL4
National Institutes of Health
Grant: 5R01CA291968-02
A Multiplatform Approach to Develop ENL-Targeting Molecules as Drug Candidates for Acute Myeloid Leukemia
National Institutes of Health
Grant: 1R01CA252707-01A1
Molecular analysis of ASH1L
Fields of Study
Keywords